A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

SIMPLE SUMMARY: Neoadjuvant chemotherapy is now a standard of care not only to decrease tumor size for breast conserving operation but also to assess drug response of an in situ cancer. Although the triple-negative subtype typically responds better compared to the other subtypes, a pathological comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshi, Masanori, Angarita, Fernando A., Tokumaru, Yoshihisa, Yan, Li, Matsuyama, Ryusei, Endo, Itaru, Takabe, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156144/
https://www.ncbi.nlm.nih.gov/pubmed/34065619
http://dx.doi.org/10.3390/cancers13102401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156144/
https://www.ncbi.nlm.nih.gov/pubmed/34065619
http://dx.doi.org/10.3390/cancers13102401

Ejemplares similares